This drugmaker is taking an unprecedented approach to getting its cancer treatment approved – Business Insider

This drugmaker is taking an unprecedented approach to getting its cancer treatment approved – Business Insider

Business InsiderThis drugmaker is taking an unprecedented approach to getting its cancer treatment approvedBusiness Insider”It carries through on the promise of treating cancer based on a genetically defined population,” CEO Dr. Josh Bilenker told Business Insider. Based on what the FDA’s told Loxo, the hope is to get approved, “for the treatment of unresectable or …and more »
This drugmaker is taking an unprecedented approach to getting its cancer treatment approved – Business Insider